Swiezewska E, Danikiewicz W. Polyisoprenoids: structure, biosynthesis and function. Prog Lipid Res. 2005;44:235–58.
Article CAS PubMed Google Scholar
Thorn RG, Malloch DW, Saar I, Lamoureux Y, Nagasawa E, Redhead SA, et al. New species in the Gymnopilus junonius group (Basidiomycota: Agaricales). Botany. 2020;98:293–315.
Nozoe S, Koike Y, Tsuji E, Kusano G, Seto H. Isolation and structure of gymnoprenols, a novel type of polyisoprenepolyols from Gymnopilus spectabilis. Tetrahedron Lett. 1983;24:1731–4.
Nozoe S, Koike Y, Kusano G, Seto H. Structure of gymnopilin, a bitter principle of a hallucinogenic mushroom, Gymnopilus spectabilis. Tetrahedron Lett. 1983;24:1735–6.
Aoyagi F, Maeno S, Okuno T, Matsumoto H, Ikura M, Hikichi K, et al. Gymnopilins, bitter principles of the big-laughter mushroom Gymnopilus spectabilis. Tetrahedron Lett. 1983;24:1991–4.
Nozoe S, Koike Y, Kusano G. Absolute stereochemistry of the triol moiety of gymnoprenols. Tetrahedron Lett. 1984;25:1371–2.
Hanson RM. Absolute stereochemistry of the triol moiety of gymnoprenols: a reinvestigation. Tetrahedron Lett. 1984;25:3783–6.
Nozoe S, Koike Y, Tsuji E, Kusano G. Revision of the absolute configuration of triol moiety of gymnoprenol. Tetrahedron Lett. 1984;25:4023–4.
Nozoe S, Koike Y, Ito N, Kusano G. Isolation and structure of gymnoprenol-D, a homologus series of fully hydrated polyisoprenepolyol from Gymnopilus spectabilis. Chem Lett. 1984;13:1001–2.
Findlay JA, He Z-Q. Minor constituents of Gymnopilus spectabilis. J Nat Prod. 1991;54:184–9.
Tanaka M, Hashimoto K, Okuno T, Shirahama H. Neurotoxic oligoisoprenoids of the hallucinogenic mushroom, Gymnopilus spectabilis. Phytochemistry. 1993;34:661–4.
Kim KH, Choi SU, Lee KR. Gymnopilin K: a new cytotoxic gymnopilin from Gymnopilus spectabilis. J Antibiot. 2011;65:135–7.
Ohta T, Aizawa K, Kamo S, Tabei N, Oshima Y, Nozoe S. Stereochemistry of polyisoprenepolyols isolated from fungi genus Gymnopilus. Symp Chem Nat Prod. 1996;38:307–2.
Tomoda H, Huang XH, Nishida H, Masuma R, Kim YK, Omura S. Glisoprenins, new inhibitors of acyl-CoA: cholesterol acyltransferase produced by Gliocladium sp. FO-1513. 1. Production, isolation and physico-chemical and biological properties. J Antibiot. 1992;45:1202–6.
Nishida H, Huang X-H, Tomoda H. Ōmura S. Glisoprenins, new inhibitors of acyl-CoA: cholesterol acyltransferase produced by Gliocladium sp. FO-1513. II. Structure elucidation of glisoprenins A and B. J Antibiot. 1992;45:1669–76.
Thines E, Eilbet F, Anke H, Sterner O. Glisoprenins C, D and E, new inhibitors of appressorium formation in Magnaporthe grisea, from cultures of Gliocladium roseum. 1. Production and biological activities. J Antibiot. 1998;51:117–22.
Sterner O, Thines E, Eilbet F, Anke H. Glisoprenins C, D and E, new inhibitors of appressorium formation in Magnaporthe grisea, from cultures of Gliocladium roseum. 2. Structure determination. J Antibiot. 1998;51:228–31.
Joshi BK, Gloer JB, Wicklow DT. New verticillin and glisoprenin A analogues from Gliocladium catenulatum, a Mycoparasite of Aspergillus flavus Sclerotia. J Nat Prod. 1999;62:730–3.
Article CAS PubMed Google Scholar
Hegde VR, Dai P, Chu M, Patel M, Bryant R, Terracciano J, et al. Neurokinin receptor inhibitors: fermentation, isolation, physico-chemical properties, structure and biological activity. J Antibiot. 1997;50:983–91.
Sawabe A, Morita M, Kiso T, Kishine H, Ohtsubo Y, Ouchi S, et al. Structural analysis of a precursory substance of bitterness: new polyisoprenepolyols isolated from an edible mushroom (Hypsizigus marmoreus) by fast atom bombardment mass spectrometry. J Agric Food Chem. 1999;47:588–93.
Article CAS PubMed Google Scholar
Sawabe A, Morita M, Ouchi S, Okamoto T. Structural characterization of a precursory substance of bitterness, new polyisoprenepolyols isolated from an edible mushroom by FAB/MS. Bull Inst Compr Agr Sci Kinki Univ. 2001;9:97–105.
Aoki S, Aboshi T, Onodera T, Kimura KI, Arai D, Iizuka Y, et al. Omphaloprenol A: a new bioactive polyisoprenepolyol isolated from the mycelium of poisonous mushroom Omphalotus japnonicus. Biosci Biotechnol Biochem. 2021;85:1364–70.
Sivasankarreddy K, Joseph J, PP T, K p, Thayyil P, Mathew D, et al. An insight into bacterial wilt of eggplant—a review. Trop Plant Pathol. 2024;49:746–64.
Smith AH. Mushrooms in their natural habitats. Sawyer's Inc. Portland, Oregon, USA.1949; p. 626.
Orton PD. New check list of British agarics and boleti. Trans Brit Mycol Soc. 1960;43:159–439.
Kurono G, Sakai T, Tochiori K. Studies on the Culture of Pholiota spectabilis Fr. (Japanese big laughing toadstool). Kanazawa-Daigaku-Yakugakubu-Kenkyu-Nempo (Ann Rep Fac Pharm Kanazawa Univ). 1956;6:1–23 (in Japanese). https://kanazawa-u.repo.nii.ac.jp/records/25780.
Kusano G, Koike Y, Inoue H, Nozoe T. The constituents of Gymnopilus spectabilis. Chem Pharm Bull. 1986;34:3465–70.
Lee IK, Cho SM, Seok SJ, Yun BS. Chemical constituents of Gymnopilus spectabilis and their antioxidant activity. Mycobiology. 2008;36:55–9.
Article CAS PubMed PubMed Central Google Scholar
Jung B, Heo EJ, Nguyen DL, Youn UJ, Kim KH, Son B, et al. Antimicrobial steroids from poisonous mushroom Gymnopilus orientispectabilis and their molecular docking studies. Separations. 2025;12:23.
Núñez-Alarcón J, Paredes JC, Carmona MT, Quiñones M. Ostopanic acid, a cytotoxic fatty acid from Gymnopilus spectabilis. Bol Soc Chil Quim. 2000;46:227–9.
Lee S, Ryoo R, Choi JH, Kim JH, Kim SH, Kim KH. Trichothecene and tremulane sesquiterpenes from a hallucinogenic mushroom Gymnopilus junonius and their cytotoxicity. Arch Pharm Res. 2020;43:214–23.
Article CAS PubMed Google Scholar
Lee S, Kim CS, Yu JS, Kang H, Yoo MJ, Youn UJ, et al. Ergopyrone, a styrylpyrone-fused steroid with a hexacyclic 6/5/6/6/6/5 skeleton from a mushroom Gymnopilus orientispectabilis. Org Lett. 2021;23:3315–9.
Article CAS PubMed Google Scholar
Lee S, Jang M, Ryoo R, Roh J, Ko SK, Kim KH. New autophagy-modulating lanostane-type triterpenoids from a hallucinogenic poisonous mushroom Gymnopilus orientispectabilis. Arch Pharm Res. 2024;47:272–87.
Article CAS PubMed Google Scholar
Didloff J, Boukes GJ, Nyambe MN, Beukes DR, Lerata MS, Vilane V, et al. Exploring antimycobacterial potential: safety evaluation and active compound isolation from Gymnopilus junonius. Antibiotics. 2025;14:79.
Oku N, Netsu R, Kurokawa Y, Igarashi Y, Phaeolschidin F, a new symmetrical bis(styrylpyrone) derivative with redox-catalyzing activity from the mushroom Gymnopilus aeruginosus (order Agaricales). J Antibiot. 2023;76:236–8.
Harigaya H. Studies on the stereochemistry of gymnopilins, the poisonous principles of Gymnopilus spectabilis. Ph.D. Dissertation, Hokkaido University, 1994. https://eprints.lib.hokudai.ac.jp/dspace/handle/2115/51267.
Hossain TJ. Methods for screening and evaluation of antibacterial activity: a review of protocols, advantages, and limitation. Eur J Microbiol Immunol. 2024;14:97–115.
Oku N, Matsumoto M, Yonejima K, Tansei K, Igarashi Y. Sacrolide A, a new antimicrobial and cytotoxic oxylipin macrolide from the edible cyanobacterium Aphanothece sacrum. Beilstein J Org Chem. 2014;10:1808–16.
Comments (0)